Registration for PET (Positron Emission Tomography) scan services at government hospitals has officially resumed following a temporary disruption in the availability of the service.
The suspension, which began on March 27, 2026, was caused by a shortage of a key radioactive tracer used in the scanning process. The radiopharmaceutical, essential for conducting PET imaging, had been unavailable due to regulatory registration issues involving the company responsible for importing the material.
The service interruption led to a complete halt of PET scan procedures across public hospitals during the affected period.
Deputy Minister of Health Hansaka Wijemuni confirmed that the supply chain has now been restored and that the required medical materials will be imported regularly going forward to prevent further disruptions.
PET scans are an advanced diagnostic imaging tool widely used in modern medicine. They play a crucial role in detecting cancer cells, assessing the spread of disease throughout the body, and evaluating the effectiveness of treatment by monitoring whether cancerous activity has been successfully eliminated.
With services now reinstated, patients requiring critical cancer diagnostics will once again have access to timely and essential medical screening at government hospitals.

